Thank you for subscribing to our blog.
We’ll hit your inbox next week with our latest post.

Latest Insights and Updates Delivered to your Inbox!

Subscribe now for exciting weekly industry news!

Navitas Earns EcoVadis Award for Second Year in a Row
Navitas has been awarded the EcoVadis Bronze Medal for the second consecutive year, showcasing the organization’s commitment to Environmental, Social and Governance (ESG) principles and responsible business practices. What is the EcoVadis Bronze Medal? EcoVadis is one of the world’s most recognized sustainability assessment platforms,...
Key Changes in EU Pharmacovigilance Regulation 2025/1466 for MAHs
Understanding Commission Implementing Regulation (EU) 2025/1466 and Pharmacovigilance in 2026 and Beyond Commission Implementing Regulation (EU) 2025/1466, adopted on 22 July 2025 and implemented on 12 February 2026, marks one of the most significant updates to EU pharmacovigilance (PV) practice since the introduction of Implementing Regulation (EU...
Key Insights from PHUSE APAC Connect 2026
PHUSE APAC Connect 2026 brought together clinical data leaders, programmers and statisticians from across the region, and Navitas Life Sciences was proud to be part of the conversation. (from left to right) – Sheikh Ibrahim, Pradip Sivaramakrishnan, Swapnil Udasi, Neeraj Malhotra, Anbarasan Durairajan , RamMohan Konda, Rahul Somavanshi. --> W...
Data Management in Clinical Trials with AI Automation
What Is Data Management in Clinical Trials? Data management in clinical trials is the structured process of collecting, validating, cleaning, standardizing and preparing clinical trial data for statistical analysis and regulatory submission. How does data management work in clinical trials? In simple terms, clinical data management ensures that tri...
What the Clinical Trial Industry Must Do by 2036
The biopharmaceutical industry is approaching a defining moment. Scientific breakthroughs across cell and gene therapies, precision oncology and novel biologics are accelerating faster than the systems designed to test them. This perspective is informed by recent industry thought leadership, including insights published by McKinsey & Company on...
Top 10 Advantages of Using Navitas Advisory Services in Pharma and Biotech
In an industry defined by scientific complexity, global regulatory shifts and rising expectations for speed and quality, pharma and biotech organizations increasingly rely on life sciences consulting services that offer both strategic foresight and operational depth. Navitas Life Sciences stands apart as a pharma and biotech advisory partner with t...
How Foundations Can Build Efficient, Patient-Centric Clinical Registries
Patient registries have become one of the most powerful tools Foundations can use to advance research, improve care and amplify the patient voice. They inform real-world evidence generation. They guide standards of care. They influence policy, funding and therapeutic development. And yet, many registries fail quietly. Not because of poor intent or ...
Leveraging AI in Labeling
From Regulatory Necessity to Strategic Advantage AI in Labeling is emerging as an important milestone. After all, labeling has long been one of the most critical yet understated functions in life sciences. For years, its primary mandate was to ensure compliance, reflect approved data accurately and meet regulatory expectations across markets. The w...
Contract Research Organisation vs Clinical Research Organisation (CRO vs CRO): What’s the Real Difference?
In life sciences outsourcing, few terms are used as interchangeably, and as confusingly, as Contract Research Organisation and Clinical Research Organisation. Both are commonly shortened to CRO, both support sponsors across drug development, and both play a critical role in bringing therapies to patients faster. So what actually differentiates a Co...
Clinical Trial Trends in 2026
How AI in Clinical Trials, Decentralized Clinical Trials and Real-World Evidence (RWE) Are Redefining Research Clinical research is entering 2026 with rising complexity and rising expectations. Sponsors are under pressure to accelerate development timelines, manage global operations, meet evolving regulatory requirements and deliver patient-centric...

Solutions

Advisory Services

Clinical Development

Post Marketing

Therapeutics

Core Therapeutics

Interdisciplinary Therapeutics

Niche Therapeutics

Sectors

Governance

About Us